HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kari Alitalo Selected Research

Hemorrhage

1/2011Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity.
4/2007Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
9/2006Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kari Alitalo Research Topics

Disease

80Neoplasms (Cancer)
12/2022 - 04/2002
33Inflammation (Inflammations)
04/2024 - 05/2002
27Neoplasm Metastasis (Metastasis)
01/2020 - 04/2002
17Lymphedema (Milroy Disease)
11/2022 - 07/2002
14Lymphatic Metastasis
01/2020 - 04/2002
10Edema (Dropsy)
01/2020 - 09/2002
10Hyperplasia
01/2020 - 03/2004
9Cardiomegaly (Heart Hypertrophy)
04/2024 - 10/2008
9Hypertrophy
01/2023 - 10/2008
9Carcinogenesis
01/2016 - 12/2004
8Hypoxia (Hypoxemia)
01/2020 - 10/2004
7Ischemia
11/2016 - 06/2003
7Carcinoma (Carcinomatosis)
03/2013 - 02/2004
6Atherosclerosis
03/2023 - 10/2003
6Adenoma (Adenomas)
01/2021 - 05/2008
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 02/2005
6Melanoma (Melanoma, Malignant)
01/2017 - 08/2005
6Pathologic Neovascularization
01/2015 - 09/2008
5Hypertension (High Blood Pressure)
01/2023 - 10/2008
5Breast Neoplasms (Breast Cancer)
09/2020 - 04/2002
5Arteriosclerosis
03/2010 - 05/2002
4Infections
11/2023 - 02/2005
4Heart Failure
01/2023 - 12/2012
4Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 05/2014
4Vascular Remodeling
01/2017 - 09/2002
4Obesity
11/2016 - 02/2015
4Wounds and Injuries (Trauma)
07/2008 - 07/2002
3Neuroinflammatory Diseases
04/2024 - 01/2020
3Insulin Resistance
12/2021 - 02/2015
3Pathologic Processes
11/2015 - 08/2004
3Ovarian Neoplasms (Ovarian Cancer)
03/2013 - 02/2008
3Hemorrhage
01/2011 - 09/2006
2Myocardial Infarction
04/2024 - 01/2021
2Nervous System Diseases (Neurological Disorders)
04/2024 - 05/2023
2Ischemic Stroke
04/2024 - 05/2023
2Stroke (Strokes)
04/2024 - 05/2023
2Lung Injury
01/2022 - 08/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 11/2002
2Infarction (Infarctions)
01/2020 - 09/2008
2Glioma (Gliomas)
12/2017 - 07/2003
2Chylothorax
09/2017 - 02/2014
2Weight Gain
11/2016 - 02/2015
2Adenocarcinoma
01/2016 - 10/2010
2Glaucoma
09/2014 - 09/2014

Drug/Important Bio-Agent (IBA)

68Vascular Endothelial Growth Factor CIBA
04/2024 - 01/2002
56Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 03/2002
38Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2022 - 03/2002
25Vascular Endothelial Growth Factor DIBA
01/2016 - 01/2002
20Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2023 - 05/2002
17Vascular Endothelial Growth Factor BIBA
04/2024 - 02/2005
17LigandsIBA
11/2021 - 04/2002
13Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 - 06/2002
10Proteins (Proteins, Gene)FDA Link
04/2024 - 02/2004
10CytokinesIBA
01/2021 - 03/2002
9AngiopoietinsIBA
03/2023 - 05/2010
9Angiopoietin-2IBA
01/2021 - 09/2002
9Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2015 - 10/2003
8Transcription Factors (Transcription Factor)IBA
12/2022 - 03/2005
8Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2020 - 04/2002
8Phosphotransferases (Kinase)IBA
10/2015 - 09/2003
8Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015 - 09/2002
7AntibodiesIBA
11/2023 - 04/2002
7Messenger RNA (mRNA)IBA
01/2023 - 01/2002
5TIE-2 Receptor (Receptor, TIE 2)IBA
03/2023 - 09/2002
5Blocking AntibodiesIBA
01/2021 - 09/2010
5EnzymesIBA
09/2020 - 04/2002
5Vascular Endothelial Growth FactorsIBA
01/2020 - 09/2002
5CollagenIBA
05/2015 - 06/2003
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2011 - 03/2002
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2023 - 03/2002
4SaltsIBA
01/2023 - 05/2009
4CateninsIBA
01/2022 - 05/2014
4TIE Receptors (TIE Receptor Tyrosine Kinases)IBA
01/2022 - 05/2010
4Therapeutic UsesIBA
10/2015 - 01/2005
4Angiopoietin-1IBA
06/2009 - 03/2003
4EndostatinsIBA
12/2007 - 10/2002
4Collagen Type XVIII (Type XVIII Collagen)IBA
12/2007 - 10/2002
3Insulin (Novolin)FDA Link
12/2021 - 10/2006
3IntegrinsIBA
01/2020 - 01/2012
3Keratin-14 (Keratin 14)IBA
11/2016 - 05/2009
3LipidsIBA
04/2016 - 03/2010
2Protein Isoforms (Isoforms)IBA
04/2024 - 10/2010
2Cell Adhesion MoleculesIBA
01/2023 - 05/2015
2ChemokinesIBA
01/2023 - 01/2021
2Adenosine Triphosphate (ATP)IBA
01/2023 - 03/2005
2AntigensIBA
01/2020 - 05/2009
2Bevacizumab (Avastin)FDA Link
07/2019 - 11/2012
2Doxycycline (Periostat)FDA LinkGeneric
09/2017 - 02/2014
2Anti-Bacterial Agents (Antibiotics)IBA
11/2016 - 02/2005
2CarcinogensIBA
01/2016 - 12/2007
2Tyrosine Kinase InhibitorsIBA
10/2015 - 06/2008
2Angiotensin IIIBA
10/2015 - 10/2008
2Annexin A1IBA
09/2015 - 09/2014
2Indicators and Reagents (Reagents)IBA
05/2015 - 08/2005
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2015 - 03/2005
2LDL Receptors (LDL Receptor)IBA
06/2014 - 08/2005

Therapy/Procedure

28Therapeutics
02/2024 - 06/2002
7Drug Therapy (Chemotherapy)
12/2017 - 03/2002
4Radiotherapy
09/2020 - 12/2007
2Immunotherapy
01/2020 - 01/2016